TNON vs. IONM, AEMD, GMVDF, QNRX, AFIB, STSS, INVO, DYNT, RSLS, and VERO
Should you be buying Tenon Medical stock or one of its competitors? The main competitors of Tenon Medical include Assure (IONM), Aethlon Medical (AEMD), G Medical Innovations (GMVDF), Quoin Pharmaceuticals (QNRX), Acutus Medical (AFIB), Sharps Technology (STSS), INVO Bioscience (INVO), Dynatronics (DYNT), ReShape Lifesciences (RSLS), and Venus Concept (VERO). These companies are all part of the "surgical & medical instruments" industry.
Tenon Medical (NASDAQ:TNON) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, community ranking, institutional ownership, media sentiment and risk.
In the previous week, Tenon Medical had 1 more articles in the media than Assure. MarketBeat recorded 10 mentions for Tenon Medical and 9 mentions for Assure. Assure's average media sentiment score of 0.66 beat Tenon Medical's score of 0.36 indicating that Assure is being referred to more favorably in the news media.
Tenon Medical and Assure both received 3 outperform votes by MarketBeat users. However, 100.00% of users gave Tenon Medical an outperform vote while only 27.27% of users gave Assure an outperform vote.
Tenon Medical has a beta of 2.21, indicating that its share price is 121% more volatile than the S&P 500. Comparatively, Assure has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500.
Assure has a net margin of 0.00% compared to Tenon Medical's net margin of -532.14%. Tenon Medical's return on equity of -934.11% beat Assure's return on equity.
Tenon Medical presently has a consensus target price of $3.00, suggesting a potential upside of 242.86%. Assure has a consensus target price of $4.00, suggesting a potential upside of 740.34%. Given Assure's higher possible upside, analysts plainly believe Assure is more favorable than Tenon Medical.
Tenon Medical has higher revenue and earnings than Assure.
22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 8.4% of Tenon Medical shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
Tenon Medical beats Assure on 9 of the 14 factors compared between the two stocks.
Get Tenon Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TNON and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TNON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tenon Medical Competitors List
Related Companies and Tools
